MANAL ABDELHACK: Open Payments
NPI 1285350777 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,330 in 60 payments from 17 companies in 2025. Trend: 2023 $686 · 2024 $1,152 · 2025 $1,330
Food & beverage: $1,330
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $414 |
| GlaxoSmithKline, LLC. | 12 | $218 |
| Insmed, Inc. | 8 | $138 |
| Inspire Medical Systems, Inc. | 4 | $82 |
| Verona Pharma, Inc. | 3 | $74 |
| Amgen Inc. | 3 | $71 |
| HARMONY BIOSCIENCES LLC | 1 | $46 |
| GENZYME CORPORATION | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Pulmonx Corporation | 1 | $35 |
Products named: FASENRA, NUCALA, Arikayce, BREZTRI, TEZSPIRE, INSPIRE, Ohtuvayre, DUPIXENT.
Industry payments across FL — which companies pay providers there.
